150 related articles for article (PubMed ID: 19371960)
1. Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers.
Loubiere S; Boyer S; Protopopescu C; Bonono CR; Abega SC; Spire B; Moatti JP
Health Policy; 2009 Oct; 92(2-3):165-73. PubMed ID: 19371960
[TBL] [Abstract][Full Text] [Related]
2. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon.
Boyer S; Eboko F; Camara M; Abé C; Nguini ME; Koulla-Shiro S; Moatti JP
AIDS; 2010 Jan; 24 Suppl 1():S5-15. PubMed ID: 20023440
[TBL] [Abstract][Full Text] [Related]
3. Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care.
Rasson S; Boyer S; Fugon L; Protopopescu C; Marcellin F; Koulla-Shiro S; Kouanfack C; Spire B; Moatti JP; Carrieri MP;
Antivir Ther; 2011; 16(3):423-8. PubMed ID: 21555826
[TBL] [Abstract][Full Text] [Related]
4. Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
Marcellin F; Protopopescu C; Abé C; Boyer S; Blanche J; Ongolo-Zogo P; Koulla-Shiro S; Moatti JP; Carrieri MP; Spire B;
AIDS Care; 2010 Apr; 22(4):441-51. PubMed ID: 20140791
[TBL] [Abstract][Full Text] [Related]
5. Current progress of China's free ART program.
Zhang FJ; Pan J; Yu L; Wen Y; Zhao Y
Cell Res; 2005; 15(11-12):877-82. PubMed ID: 16354563
[TBL] [Abstract][Full Text] [Related]
6. Delayed first consultation after diagnosis of HIV infection in Cameroon.
Marcellin F; Abé C; Loubière S; Boyer S; Blanche J; Koulla-Shiro S; Ongolo-Zogo P; Moatti JP; Spire B; Carrieri MP;
AIDS; 2009 May; 23(8):1015-9. PubMed ID: 19339871
[TBL] [Abstract][Full Text] [Related]
7. [Access to the management of HIV infected children: Overview of the healthcare supply in Cameroon in 2014].
Penda CI; Zoung Kanyi Bissek AC; Téjiokem MC; Sofeu CL; Eboumbou Moukoko EC; Ateba Ndongo F; Njock LR; Koki Ndombo PO
Rev Epidemiol Sante Publique; 2020 Aug; 68(4):243-251. PubMed ID: 32631665
[TBL] [Abstract][Full Text] [Related]
8. HIV treatment in times of civil strife: serious threats to antiretroviral drug access in the Kibera slum following the Kenyan elections.
Unge C; Södergård B; Thorson A; Ragnarsson A; Carter J; Ilako F; Waweru M; Ekström AM
AIDS; 2008 Aug; 22(13):1693-4. PubMed ID: 18670238
[No Abstract] [Full Text] [Related]
9. [Factors associated with antiretroviral treatment and their influence on health related quality of life in HIV infected patients].
Briongos-Figuero LS; Bachiller-Luque P; Palacios-Martín T; de Luis-Román DA; Eiros-Bouza JM
Enferm Infecc Microbiol Clin; 2011 Jan; 29(1):9-13. PubMed ID: 21208696
[TBL] [Abstract][Full Text] [Related]
10. Barriers to access to antiretroviral treatment in developing countries: a review.
Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
[TBL] [Abstract][Full Text] [Related]
11. Equity in the use of antiretroviral treatment in the public health care system in urban South Africa.
Cleary S; Silal S; Birch S; Carrara H; Pillay-van Wyk V; Rehle T; Schneider H
Health Policy; 2011 Mar; 99(3):261-6. PubMed ID: 21075470
[TBL] [Abstract][Full Text] [Related]
12. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
13. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
[TBL] [Abstract][Full Text] [Related]
14. Inequalities in health: access to treatment for HIV/AIDS.
Giuliano M; Vella S
Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
[TBL] [Abstract][Full Text] [Related]
15. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
16. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116).
Marcellin F; Boyer S; Protopopescu C; Dia A; Ongolo-Zogo P; Koulla-Shiro S; Abega SC; Abé C; Moatti JP; Spire B; Carrieri MP;
Trop Med Int Health; 2008 Dec; 13(12):1470-8. PubMed ID: 19000156
[TBL] [Abstract][Full Text] [Related]
17. Unequal access to ART: exploratory results from rural and urban case studies of ART use.
Cleary SM; Birch S; Moshabela M; Schneider H
Sex Transm Infect; 2012 Mar; 88(2):141-6. PubMed ID: 22345029
[TBL] [Abstract][Full Text] [Related]
18. [Primary results of antiretroviral treatment among HIV/AIDS infected children in Lomé (Togo)].
Atakouma DY; Tsolenyanu E; Gbadoe A; Gbetoglo V; Lawson-Evi K; Agbere AR; Tatagan-Agbi K; Assimadi K
Arch Pediatr; 2007 Oct; 14(10):1178-82. PubMed ID: 17531452
[TBL] [Abstract][Full Text] [Related]
19. The challenges to scaling up antiretroviral therapy in Papua New Guinea.
Raynes P; Maibani G
P N G Med J; 2006; 49(1-2):32-42. PubMed ID: 18396610
[TBL] [Abstract][Full Text] [Related]
20. Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes.
Myer L; Rebe K; Morroni C
Trop Med Int Health; 2007 Dec; 12(12):1484-9. PubMed ID: 18076556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
